AI Verdict
IMMX has stronger fundamentals based on our AI analysis.
IMMX vs IMDX Fundamental Comparison
| Metric | IMMX | IMDX |
|---|---|---|
| Revenue | $20.0M | $4.1M |
| Net Income | $-29.4M | $-50.2M |
| Net Margin | -147.2% | -1,238.5% |
| ROE | -31.4% | N/A |
| ROA | -28.1% | -195.0% |
| Current Ratio | 10.01x | 1.27x |
| Debt/Equity | 0.00x | N/A |
| EPS | $-0.89 | $-1.65 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMMX vs IMDX: Frequently Asked Questions
Is IMMX or IMDX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMMX has stronger fundamentals. IMMX is rated SELL (75% confidence) while IMDX is rated STRONG SELL (88% confidence). This is not investment advice.
How does IMMX compare to IMDX fundamentally?
Immix Biopharma, Inc. has ROE of -31.4% vs Insight Molecular Diagnostics Inc.'s N/A. Net margins are -147.2% vs -1,238.5% respectively.
Which stock pays higher dividends, IMMX or IMDX?
IMMX has a dividend yield of N/A or no dividend while IMDX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMMX or IMDX for long term?
For long-term investing, consider that IMMX has SELL rating with 75% confidence, while IMDX has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMMX vs IMDX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMMX vs IMDX, the AI consensus favors IMMX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.